Stay updated on Daratumumab Plus Ibrutinib in Waldenstrӧm's Clinical Trial

Sign up to get notified when there's something new on the Daratumumab Plus Ibrutinib in Waldenstrӧm's Clinical Trial page.
Latest website image capture
Clouds background image

Latest updates to the Daratumumab Plus Ibrutinib in Waldenstrӧm's Clinical Trial page

  1. Check
    yesterday
    No Change Detected
  2. Check
    9 days ago
    No Change Detected
  3. Check
    16 days ago
    Change Detected
    Summary
    The page’s displayed “Revision” version number was updated from v3.5.2 to v3.5.3.
    Difference
    0.1%
    Check dated 2026-04-24T22:39:57.000Z thumbnail image
  4. Check
    23 days ago
    Change Detected
    Summary
    The page now displays Revision: v3.5.2, and the previous Revision: v3.5.0 has been removed.
    Difference
    0.1%
    Check dated 2026-04-17T14:09:06.000Z thumbnail image
  5. Check
    52 days ago
    Change Detected
    Summary
    Revision updated from v3.4.3 to v3.5.0 on the page.
    Difference
    0.1%
    Check dated 2026-03-19T23:52:17.000Z thumbnail image
  6. Check
    59 days ago
    Change Detected
    Summary
    Revision status updated to v3.4.3, replacing the previous v3.4.2.
    Difference
    0.1%
    Check dated 2026-03-12T20:16:48.000Z thumbnail image
  7. Check
    88 days ago
    Change Detected
    Summary
    Revision updated from v3.4.1 to v3.4.2. To avoid being alerted by small changes, set an alert condition by clicking below.
    Difference
    0.1%
    Check dated 2026-02-12T02:19:02.000Z thumbnail image
  8. Check
    95 days ago
    Change Detected
    Summary
    Page revision updated from v3.4.0 to v3.4.1, a minor update that does not modify study details or how users interact with the page. To avoid being alerted by small changes, set an alert condition by clicking below.
    Difference
    0.1%
    Check dated 2026-02-04T17:51:27.000Z thumbnail image

Stay in the know with updates to Daratumumab Plus Ibrutinib in Waldenstrӧm's Clinical Trial

Enter your email address, and we'll notify you when there's something new on the Daratumumab Plus Ibrutinib in Waldenstrӧm's Clinical Trial page.